Repurgenesis presented its AI-driven drug repurposing platform, Intelligent Orchestrator, at the Taipei Biotech Pavilion during BIO Asia–Taiwan 2026. General Manager Yin-Hsong Hsu shared the platform’s development progress and the company’s strategy for expanding collaboration across the global biotechnology and pharmaceutical industry.

Full Article — https://www.ttv.com.tw/finance/view/0720261615555B11B43B19AA44468BB554453D5634D013D0/587